BRECKENRIDGE FDA Approval ANDA 090176

ANDA 090176

BRECKENRIDGE

FDA Drug Application

Application #090176

Application Sponsors

ANDA 090176BRECKENRIDGE

Marketing Status

Prescription001

Application Products

001SPRAY, METERED;NASALEQ 0.125MG BASE/SPRAY0AZELASTINE HYDROCHLORIDEAZELASTINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2015-07-28
LABELING; LabelingSUPPL4AP2021-04-30STANDARD
LABELING; LabelingSUPPL7AP2021-04-30STANDARD

Submissions Property Types

ORIG1Null42
SUPPL4Null7
SUPPL7Null15

TE Codes

001PrescriptionAB

CDER Filings

BRECKENRIDGE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90176
            [companyName] => BRECKENRIDGE
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZELASTINE HYDROCHLORIDE","activeIngredients":"AZELASTINE HYDROCHLORIDE","strength":"EQ 0.125MG BASE\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AZELASTINE HYDROCHLORIDE","submission":"AZELASTINE HYDROCHLORIDE","actionType":"EQ 0.125MG BASE\/SPRAY","submissionClassification":"SPRAY, METERED;NASAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.